Use of Bismuth in Irritable Bowel Syndrome

Aim. An evidence review on use of bismuth in irritable bowel syndrome.Key points. Irritable bowel syndrome (IBS) is a common functional disorder significantly impacting the quality of life and social status, i.a., through frequent manifestations of diarrhea. Postinfectious IBS emerges after a bacter...

Full description

Saved in:
Bibliographic Details
Main Author: T. A. Ilchishina
Format: Article
Language:Russian
Published: Gastro LLC 2021-10-01
Series:Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:
Online Access:https://www.gastro-j.ru/jour/article/view/579
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823860161454800896
author T. A. Ilchishina
author_facet T. A. Ilchishina
author_sort T. A. Ilchishina
collection DOAJ
description Aim. An evidence review on use of bismuth in irritable bowel syndrome.Key points. Irritable bowel syndrome (IBS) is a common functional disorder significantly impacting the quality of life and social status, i.a., through frequent manifestations of diarrhea. Postinfectious IBS emerges after a bacterial, pro-tozoan or viral intestinal disease. The new coronavirus pandemic supposedly affects most factors involved in functional disorder developments and may serve a fuelling cause of postinfectious IBS. Bismuth salts accumulate cytoprotective, anti-inflammatory and antibacterial properties. Therapeutic efficacy of bismuth compounds has been demonstrated in treatment of diarrhea-accompanied diseases of   various etiology, including postinfectious IBS. The use of therapeutic-dosed bismuth preparations is safe and well tolerated by patients.Conclusion. Use of bismuth may be considered a treatment and prevention approach in diarrhea-predominant IBS, both in monotherapy and combined regimens.
format Article
id doaj-art-d94743c572b74a8e8ddfb5fd098295e7
institution Kabale University
issn 1382-4376
2658-6673
language Russian
publishDate 2021-10-01
publisher Gastro LLC
record_format Article
series Российский журнал гастроэнтерологии, гепатологии, колопроктологии
spelling doaj-art-d94743c572b74a8e8ddfb5fd098295e72025-02-10T16:14:36ZrusGastro LLCРоссийский журнал гастроэнтерологии, гепатологии, колопроктологии1382-43762658-66732021-10-01313515910.22416/1382-4376-2021-31-3-51-59425Use of Bismuth in Irritable Bowel SyndromeT. A. Ilchishina0SM-Clinic Multispecialty Medical HoldingAim. An evidence review on use of bismuth in irritable bowel syndrome.Key points. Irritable bowel syndrome (IBS) is a common functional disorder significantly impacting the quality of life and social status, i.a., through frequent manifestations of diarrhea. Postinfectious IBS emerges after a bacterial, pro-tozoan or viral intestinal disease. The new coronavirus pandemic supposedly affects most factors involved in functional disorder developments and may serve a fuelling cause of postinfectious IBS. Bismuth salts accumulate cytoprotective, anti-inflammatory and antibacterial properties. Therapeutic efficacy of bismuth compounds has been demonstrated in treatment of diarrhea-accompanied diseases of   various etiology, including postinfectious IBS. The use of therapeutic-dosed bismuth preparations is safe and well tolerated by patients.Conclusion. Use of bismuth may be considered a treatment and prevention approach in diarrhea-predominant IBS, both in monotherapy and combined regimens.https://www.gastro-j.ru/jour/article/view/579irritable bowel syndromebismuth tripotassium dicitratepostinfectious ibsdiarrhea
spellingShingle T. A. Ilchishina
Use of Bismuth in Irritable Bowel Syndrome
Российский журнал гастроэнтерологии, гепатологии, колопроктологии
irritable bowel syndrome
bismuth tripotassium dicitrate
postinfectious ibs
diarrhea
title Use of Bismuth in Irritable Bowel Syndrome
title_full Use of Bismuth in Irritable Bowel Syndrome
title_fullStr Use of Bismuth in Irritable Bowel Syndrome
title_full_unstemmed Use of Bismuth in Irritable Bowel Syndrome
title_short Use of Bismuth in Irritable Bowel Syndrome
title_sort use of bismuth in irritable bowel syndrome
topic irritable bowel syndrome
bismuth tripotassium dicitrate
postinfectious ibs
diarrhea
url https://www.gastro-j.ru/jour/article/view/579
work_keys_str_mv AT tailchishina useofbismuthinirritablebowelsyndrome